We will contribute to the advancement of glycan research and promote the health of humanity and society through drug discovery.
Ika Kagaku Sōyaku Co., Ltd. is a company that develops its business centered around reagent sales, glycan contract analysis, and glycan contract synthesis. We aim for drug discovery using our four core technologies: "GlycoBlotting method," "glycopeptide synthesis," "microparticle production technology," and "glycopeptide array." If you have any inquiries regarding glycan synthesis or analysis, please feel free to contact Ika Kagaku Sōyaku. 【Business Introduction】 ■Reagent Sales ■Glycan Analysis ■Glycan Synthesis ■Protein Quality Control *For more details, please refer to our catalog or feel free to contact us.
Inquire About This Product
basic information
【Products Offered】 ■ Reagent Sales - Sugar amino acid building blocks - Glycosyltransferases - Phosphorylcholine linkers / Aminooxy linkers - Silane coupling agents - Synthetic peptides ■ Glycan Contract Analysis - Glycan analysis using mass spectrometry - Fluorescent labeling monosaccharide composition analysis - Glycan analysis using NMR ■ Glycan Contract Synthesis - Synthesis of sugar derivatives and glycan synthesis - Sugar peptide synthesis ■ Protein Quality Control - Contract analysis of biopharmaceutical glycans - Contract synthesis of sugar peptides *For more details, please refer to the catalog or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the catalog or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Ika Chemical Co., Ltd. is a company that develops its business around the sale of reagents, contract analysis of glycan, and contract synthesis of glycan. Although we are a small company, we possess both synthesis and analysis technologies related to glycan, as well as a wide range of techniques for biochemical experiments. Among these, we aim for drug discovery using four core technologies: "GlycoBlotting method," "glycopeptide synthesis," "microparticle production technology," and "glycopeptide array."